 | RXR | Name: | [2,2,5,5-tetramethyl-3,4-bis(sulfanylmethyl)-2,5-dihydro-1H-pyrrol-1-yl]oxidanyl radical | Formula: | C10 H18 N O S2 | SMILES: | ON1C(C(=C(CS)C1(C)C)CS)(C)C | InChi: | InChI=1S/C10H19NOS2/c1-9(2)7(5-13)8(6-14)10(3,4)11(9)12/h12-14H,5-6H2,1-4H3 | Synonyms: | 3,4-bis(thiomethyl)-2,2,5,5-tetramethyl-1H-Pyrrol-1-yloxyl radical | Definition date: | 2010-01-08 | Last modified: | 2024-09-27 | Identifier: | 2,2,5,5-tetramethyl-3,4-bis(sulfanylmethyl)-2,5-dihydro-1H-pyrrol-1-ol |
|
 | WF7 | Name: | N-{4-[(E)-2-{4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl}ethenyl]phenyl}prop-2-enamide | Formula: | C24 H28 N8 O | SMILES: | n4c(C)cc(Nc3cc(N1CCN(C)CC1)nc([C@H]=[C@H]c2ccc(cc2)NC(=O)/C=C)n3)n4 | InChi: | InChI=1S/C24H28N8O/c1-4-24(33)25-19-8-5-18(6-9-19)7-10-20-26-21(27-22-15-17(2)29-30-22)16-23(28-20)32-13-11-31(3)12-14-32/h4-10,15-16H,1,11-14H2,2-3H3,(H,25,33)(H2,26,27,28,29,30)/b10-7+ | Definition date: | 2020-10-26 | Last modified: | 2024-09-27 | Release date: | 2021-02-10 | Identifier: | N-{4-[(E)-2-{4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl}ethenyl]phenyl}prop-2-enamide |
|
 | QCS | Name: | S-carbamoyl-L-cysteine | Formula: | C4 H8 N2 O3 S | SMILES: | O=C(SCC(C(=O)O)N)N | InChi: | InChI=1S/C4H8N2O3S/c5-2(3(7)8)1-10-4(6)9/h2H,1,5H2,(H2,6,9)(H,7,8)/t2-/m0/s1 | Definition date: | 2013-10-21 | Last modified: | 2024-09-27 | Release date: | 2013-12-18 | Identifier: | S-carbamoyl-L-cysteine |
|
 | TLQ | Name: | 4-(2-phenylimidazol-1-yl)naphthalene-1-carbaldehyde | Formula: | C20 H14 N2 O | SMILES: | O=Cc1ccc(n2ccnc2c3ccccc3)c4ccccc14 | InChi: | InChI=1S/C20H14N2O/c23-14-16-10-11-19(18-9-5-4-8-17(16)18)22-13-12-21-20(22)15-6-2-1-3-7-15/h1-14H | Definition date: | 2021-01-11 | Last modified: | 2024-09-27 | Release date: | 2021-06-16 | Identifier: | 4-(2-phenylimidazol-1-yl)naphthalene-1-carbaldehyde |
|
 | LFI | Name: | 1-[3,5-bis(3-bromanylpropanoyl)-1,3,5-triazinan-1-yl]-3-bromanyl-propan-1-one | Formula: | C12 H18 Br3 N3 O3 | SMILES: | BrCCC(=O)N1CN(CN(C1)C(=O)CCBr)C(=O)CCBr | InChi: | InChI=1S/C12H18Br3N3O3/c13-4-1-10(19)16-7-17(11(20)2-5-14)9-18(8-16)12(21)3-6-15/h1-9H2 | Synonyms: | Chemical crosslinker | Definition date: | 2022-07-01 | Last modified: | 2024-09-27 | Release date: | 2023-09-20 | Identifier: | 1-[3,5-bis(3-bromanylpropanoyl)-1,3,5-triazinan-1-yl]-3-bromanyl-propan-1-one |
|
 | NHN | Name: | (6R,8S,11S)-11-CYCLOHEXYL-N-(1-{[(2-{[(1S)-2-(DIMETHYLAMINO)-2-OXO-1-PHENYLETHYL]AMINO}-2-OXOETHYL)AMINO](OXO)ACETYL}BUTYL)-10,13-DIOXO-2,5-DIOXA-9,12-DIAZATRICYCLO[14.3.1.1~6,9~]HENICOSA-1(20),16,18-TRIENE-8-CARBOXAMIDE | Formula: | C42 H56 N6 O9 | SMILES: | O=C(N(C)C)C(c1ccccc1)NC(=O)CNC(=O)C(=O)C(NC(=O)C2N3C(=O)C(NC(=O)CCc4cccc(OCCOC(C2)C3)c4)C5CCCCC5)CCC | InChi: | InChI=1S/C42H56N6O9/c1-4-12-32(38(51)40(53)43-25-35(50)46-36(41(54)47(2)3)28-14-7-5-8-15-28)44-39(52)33-24-31-26-48(33)42(55)37(29-16-9-6-10-17-29)45-34(49)20-19-27-13-11-18-30(23-27)56-21-22-57-31/h5,7-8,11,13-15,18,23,29,31-33,36-37H,4,6,9-10,12,16-17,19-22,24-26H2,1-3H3,(H,43,53)(H,44,52)(H,45,49)(H,46,50)/t31-,32+,33+,36+,37+/m1/s1 | Definition date: | 2006-05-11 | Last modified: | 2024-09-27 | Identifier: | (6R,8S,11S)-11-cyclohexyl-N-[(1S)-1-{[(2-{[(1S)-2-(dimethylamino)-2-oxo-1-phenylethyl]amino}-2-oxoethyl)amino](oxo)acetyl}butyl]-10,13-dioxo-2,5-dioxa-9,12-diazatricyclo[14.3.1.1~6,9~]henicosa-1(20),16,18-triene-8-carboxamide |
|
 | RXW | Name: | (5-methyl-1H-indazol-6-yl)boronic acid | Formula: | C8 H9 B N2 O2 | SMILES: | Cc1cc2cn[nH]c2cc1B(O)O | InChi: | InChI=1S/C8H9BN2O2/c1-5-2-6-4-10-11-8(6)3-7(5)9(12)13/h2-4,12-13H,1H3,(H,10,11) | Synonyms: | 5-Methyl-1H-indazole-6-boronic acid | Definition date: | 2020-10-31 | Last modified: | 2024-09-27 | Release date: | 2021-08-11 | Identifier: | (5-methyl-1~{H}-indazol-6-yl)boronic acid |
|
 | WFD | Name: | 1-[4-(4-{4-(4-methylpiperazin-1-yl)-6-[(3-methyl-1H-pyrazol-5-yl)amino]pyrimidin-2-yl}phenyl)piperidin-1-yl]prop-2-en-1-one | Formula: | C27 H34 N8 O | SMILES: | CN1CCN(CC1)c2nc(nc(c2)Nc3cc(C)nn3)c4ccc(cc4)C5CCN(CC5)C(/C=C)=O | InChi: | InChI=1S/C27H34N8O/c1-4-26(36)35-11-9-21(10-12-35)20-5-7-22(8-6-20)27-29-23(28-24-17-19(2)31-32-24)18-25(30-27)34-15-13-33(3)14-16-34/h4-8,17-18,21H,1,9-16H2,2-3H3,(H2,28,29,30,31,32) | Definition date: | 2020-10-26 | Last modified: | 2024-09-27 | Release date: | 2021-02-10 | Identifier: | 1-[4-(4-{4-(4-methylpiperazin-1-yl)-6-[(3-methyl-1H-pyrazol-5-yl)amino]pyrimidin-2-yl}phenyl)piperidin-1-yl]prop-2-en-1-one |
|
 | TLX | Name: | N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE | Formula: | C13 H27 N3 | SMILES: | N21CCCC1N(CCC2)CC(N)CC(C)C | InChi: | InChI=1S/C13H27N3/c1-11(2)9-12(14)10-16-8-4-7-15-6-3-5-13(15)16/h11-13H,3-10,14H2,1-2H3/t12-,13+/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (2S)-1-[(8aR)-hexahydropyrrolo[1,2-a]pyrimidin-1(2H)-yl]-4-methylpentan-2-amine |
|
 | P4E | Name: | (2S,4E)-2-amino-5-phenylpent-4-enoic acid | Formula: | C11 H13 N O2 | SMILES: | O=C(O)C(N)C/C=C/c1ccccc1 | InChi: | InChI=1S/C11H13NO2/c12-10(11(13)14)8-4-7-9-5-2-1-3-6-9/h1-7,10H,8,12H2,(H,13,14)/b7-4+/t10-/m0/s1 | Definition date: | 2011-10-13 | Last modified: | 2024-09-27 | Identifier: | (2S,4E)-2-amino-5-phenylpent-4-enoic acid |
|
 | TLY | Name: | (2S)-2-azanyl-6-(ethanethioylamino)hexanoic acid | Formula: | C8 H16 N2 O2 S | SMILES: | O=C(O)C(N)CCCCNC(=S)C | InChi: | InChI=1S/C8H16N2O2S/c1-6(13)10-5-3-2-4-7(9)8(11)12/h7H,2-5,9H2,1H3,(H,10,13)(H,11,12)/t7-/m0/s1 | Synonyms: | 6-N-thiolacetyl-L-lysine | Definition date: | 2010-03-04 | Last modified: | 2024-09-27 | Identifier: | N~6~-ethanethioyl-L-lysine |
|
 | QS7 | Name: | N-[(3R,4S)-4-{[6-(2,6-dichloro-3,5-dimethoxyphenyl)-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino}oxolan-3-yl]prop-2-enamide | Formula: | C23 H23 Cl2 N5 O5 | SMILES: | c13nc(ncc1C=C(c2c(c(OC)cc(c2Cl)OC)Cl)C(N3C)=O)NC4C(COC4)NC(=O)[C@H]=C | InChi: | InChI=1S/C23H23Cl2N5O5/c1-5-17(31)27-13-9-35-10-14(13)28-23-26-8-11-6-12(22(32)30(2)21(11)29-23)18-19(24)15(33-3)7-16(34-4)20(18)25/h5-8,13-14H,1,9-10H2,2-4H3,(H,27,31)(H,26,28,29)/t13-,14+/m0/s1 | Definition date: | 2019-12-16 | Last modified: | 2024-09-27 | Release date: | 2020-03-25 | Identifier: | N-[(3R,4S)-4-{[6-(2,6-dichloro-3,5-dimethoxyphenyl)-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino}oxolan-3-yl]prop-2-enamide |
|
 | RJR | Name: | (1~{S},2~{R},3~{R},4~{S},5~{S})-4-[[4-[3-(1-adamantylmethoxy)propyl]-1,2,3-triazol-1-yl]methyl]cyclohexane-1,2,3,5-tetrol | Formula: | C23 H37 N3 O5 | SMILES: | O[CH]1C[CH](O)[CH](Cn2cc(CCCOCC34CC5CC(CC(C5)C3)C4)nn2)[CH](O)[CH]1O | InChi: | InChI=1S/C23H37N3O5/c27-19-7-20(28)22(30)21(29)18(19)12-26-11-17(24-25-26)2-1-3-31-13-23-8-14-4-15(9-23)6-16(5-14)10-23/h11,14-16,18-22,27-30H,1-10,12-13H2/t14-,15+,16-,18-,19-,20-,21+,22+,23-/m0/s1 | Definition date: | 2018-12-11 | Last modified: | 2024-09-27 | Release date: | 2019-03-27 | Identifier: | (1~{S},2~{R},3~{R},4~{S},5~{S})-4-[[4-[3-(1-adamantylmethoxy)propyl]-1,2,3-triazol-1-yl]methyl]cyclohexane-1,2,3,5-tetrol |
|
 | QS8 | Name: | [[(3~{R},6~{R})-6-fluoranyl-1-methanoyl-piperidin-3-yl]amino] hydrogen sulfate | Formula: | C6 H11 F N2 O5 S | SMILES: | O[S](=O)(=O)ON[CH]1CC[CH](F)N(C1)C=O | InChi: | InChI=1S/C6H11FN2O5S/c7-6-2-1-5(3-9(6)4-10)8-14-15(11,12)13/h4-6,8H,1-3H2,(H,11,12,13)/t5-,6+/m1/s1 | Definition date: | 2020-07-31 | Last modified: | 2024-09-27 | Release date: | 2021-08-11 | Identifier: | [[(3~{R},6~{R})-6-fluoranyl-1-methanoyl-piperidin-3-yl]amino] hydrogen sulfate |
|
 | RY2 | Name: | (3-(1H-tetrazol-5-yl)phenyl)boronic acid | Formula: | C7 H7 B N4 O2 | SMILES: | OB(O)c1cccc(c1)c2n[nH]nn2 | InChi: | InChI=1S/C7H7BN4O2/c13-8(14)6-3-1-2-5(4-6)7-9-11-12-10-7/h1-4,13-14H,(H,9,10,11,12) | Synonyms: | [3-(2H-1,2,3,4-tetrazol-5-yl)phenyl]boronic acid | Definition date: | 2020-10-31 | Last modified: | 2024-09-27 | Release date: | 2021-08-11 | Identifier: | [3-(2~{H}-1,2,3,4-tetrazol-5-yl)phenyl]boronic acid |
|
 | 5RP | Name: | RIBULOSE-5-PHOSPHATE | Formula: | C5 H11 O8 P | SMILES: | O=P(O)(O)OCC(O)C(O)C(=O)CO | InChi: | InChI=1S/C5H11O8P/c6-1-3(7)5(9)4(8)2-13-14(10,11)12/h4-6,8-9H,1-2H2,(H2,10,11,12)/t4-,5+/m1/s1 | Definition date: | 2004-07-09 | Last modified: | 2024-09-27 | Identifier: | 5-O-phosphono-D-ribulose |
|
 | QSC | Name: | (1R)-1-phenylethanamine | Formula: | C8 H11 N | SMILES: | NC(c1ccccc1)C | InChi: | InChI=1S/C8H11N/c1-7(9)8-5-3-2-4-6-8/h2-7H,9H2,1H3/t7-/m1/s1 | Definition date: | 2011-12-22 | Last modified: | 2024-09-27 | Release date: | 2012-11-16 | Identifier: | (1R)-1-phenylethanamine |
|
 | N3O | Name: | ~{N}-(3-methyl-[1,2]oxazolo[5,4-b]pyridin-5-yl)propanamide | Formula: | C10 H11 N3 O2 | SMILES: | CCC(=O)Nc1cnc2onc(C)c2c1 | InChi: | InChI=1S/C10H11N3O2/c1-3-9(14)12-7-4-8-6(2)13-15-10(8)11-5-7/h4-5H,3H2,1-2H3,(H,12,14) | Definition date: | 2022-08-11 | Last modified: | 2024-09-27 | Release date: | 2022-09-28 | Identifier: | ~{N}-(3-methyl-[1,2]oxazolo[5,4-b]pyridin-5-yl)propanamide |
|
 | V5N | Name: | (2S,3S)-2-azanyl-3-(1H-imidazol-5-yl)-3-oxidanyl-propanoic acid | Formula: | C6 H9 N3 O3 | SMILES: | N[CH]([CH](O)c1[nH]cnc1)C(O)=O | InChi: | InChI=1S/C6H9N3O3/c7-4(6(11)12)5(10)3-1-8-2-9-3/h1-2,4-5,10H,7H2,(H,8,9)(H,11,12)/t4-,5+/m0/s1 | Definition date: | 2021-04-19 | Last modified: | 2024-09-27 | Release date: | 2021-06-02 | Identifier: | (2~{S},3~{S})-2-azanyl-3-(1~{H}-imidazol-5-yl)-3-oxidanyl-propanoic acid |
|
 | TM8 | Name: | Nalpha-[(benzyloxy)carbonyl]-N-[(2S)-1-phenyl-4-(phenylsulfonyl)butan-2-yl]-L-phenylalaninamide | Formula: | C33 H34 N2 O5 S | SMILES: | N(C(OCc1ccccc1)=O)C(Cc2ccccc2)C(=O)NC(CCS(c3ccccc3)(=O)=O)Cc4ccccc4 | InChi: | InChI=1S/C33H34N2O5S/c36-32(31(24-27-15-7-2-8-16-27)35-33(37)40-25-28-17-9-3-10-18-28)34-29(23-26-13-5-1-6-14-26)21-22-41(38,39)30-19-11-4-12-20-30/h1-20,29,31H,21-25H2,(H,34,36)(H,35,37)/t29-,31+/m1/s1 | Definition date: | 2019-11-07 | Last modified: | 2024-09-27 | Release date: | 2020-11-25 | Identifier: | Nalpha-[(benzyloxy)carbonyl]-N-[(2S)-1-phenyl-4-(phenylsulfonyl)butan-2-yl]-L-phenylalaninamide |
|
 | N3X | Name: | ~{N}-[(1-methylindazol-6-yl)methyl]propanamide | Formula: | C12 H15 N3 O | SMILES: | CCC(=O)NCc1ccc2cnn(C)c2c1 | InChi: | InChI=1S/C12H15N3O/c1-3-12(16)13-7-9-4-5-10-8-14-15(2)11(10)6-9/h4-6,8H,3,7H2,1-2H3,(H,13,16) | Definition date: | 2022-08-11 | Last modified: | 2024-09-27 | Release date: | 2022-09-28 | Identifier: | ~{N}-[(1-methylindazol-6-yl)methyl]propanamide |
|
 | 5S4 | Name: | [(3~{R})-4-[[3-[2-[[(2~{S})-2-azanyl-3-methyl-butanoyl]amino]ethylamino]-3-oxidanylidene-propyl]amino]-2,2-dimethyl-3-oxidanyl-4-oxidanylidene-butyl] dihydrogen phosphate | Formula: | C16 H33 N4 O8 P | SMILES: | CC(C)[CH](N)C(=O)NCCNC(=O)CCNC(=O)[CH](O)C(C)(C)CO[P](O)(O)=O | InChi: | InChI=1S/C16H33N4O8P/c1-10(2)12(17)14(23)20-8-7-18-11(21)5-6-19-15(24)13(22)16(3,4)9-28-29(25,26)27/h10,12-13,22H,5-9,17H2,1-4H3,(H,18,21)(H,19,24)(H,20,23)(H2,25,26,27)/t12-,13-/m0/s1 | Definition date: | 2015-11-19 | Last modified: | 2024-09-27 | Release date: | 2016-01-20 | Identifier: | [(3~{R})-4-[[3-[2-[[(2~{S})-2-azanyl-3-methyl-butanoyl]amino]ethylamino]-3-oxidanylidene-propyl]amino]-2,2-dimethyl-3-oxidanyl-4-oxidanylidene-butyl] dihydrogen phosphate |
|
 | N40 | Name: | 3-cyclohexyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-N~2~-(octylsulfonyl)-L-alaninamide | Formula: | C24 H45 N3 O5 S | SMILES: | C(CCCCCCC)S(NC(CC1CCCCC1)C(NC(CO)CC2CCNC2=O)=O)(=O)=O | InChi: | InChI=1S/C24H45N3O5S/c1-2-3-4-5-6-10-15-33(31,32)27-22(16-19-11-8-7-9-12-19)24(30)26-21(18-28)17-20-13-14-25-23(20)29/h19-22,27-28H,2-18H2,1H3,(H,25,29)(H,26,30)/t20-,21-,22-/m0/s1 | Synonyms: | 3-cyclohexyl-N~2~-(octylsulfonyl)-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-alaninamide (bound form) | Definition date: | 2016-09-12 | Last modified: | 2024-09-27 | Release date: | 2016-11-23 | Identifier: | 3-cyclohexyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-N~2~-(octylsulfonyl)-L-alaninamide |
|
 | R6E | Name: | (2~{R})-2-azanyl-2-ethyl-octanoic acid | Formula: | C10 H21 N O2 | SMILES: | CCCCCC[C](N)(CC)C(O)=O | InChi: | InChI=1S/C10H21NO2/c1-3-5-6-7-8-10(11,4-2)9(12)13/h3-8,11H2,1-2H3,(H,12,13)/t10-/m1/s1 | Definition date: | 2019-05-03 | Last modified: | 2024-09-27 | Release date: | 2020-03-18 | Identifier: | (2~{R})-2-azanyl-2-ethyl-octanoic acid |
|
 | QDD | Name: | 2-(8-azanyl-2-methanoyl-quinolin-4-yl)ethanoic acid | Formula: | C12 H10 N2 O4 | SMILES: | Nc1cccc2c(CC(O)=O)cc(nc12)C(O)=O | InChi: | InChI=1S/C12H10N2O4/c13-8-3-1-2-7-6(5-10(15)16)4-9(12(17)18)14-11(7)8/h1-4H,5,13H2,(H,15,16)(H,17,18) | Definition date: | 2018-10-24 | Last modified: | 2024-09-27 | Release date: | 2019-09-18 | Identifier: | 8-azanyl-4-(2-hydroxy-2-oxoethyl)quinoline-2-carboxylic acid |
|